1. Time for a change in drug licensing requirements?;Drummond;Eur J Health Econ,2002
2. Towards a Euro-NICE?;Maynard;Eurohealth,2001
3. Quality, innovation, and value for money, NICE and the British National Health Service;Pearson;JAMA,2005
4. What could be NICER than NICE? OHE Annual Lecture;Williams,2004
5. Costas E. Un «déja vu» donde las cuentas dista de favorecer al comprador. El País, 25 de mayo de 2006; p. 62.